Literature DB >> 15491743

Association between vitamin D receptor gene polymorphisms and fasting idiopathic hypercalciuria in recurrent stone-forming patients.

Domenico Rendina1, Giuseppe Mossetti, Roberto Viceconti, Mariangela Sorrentino, Rosaria Castaldo, Giuseppe Manno, Vincenzo Guadagno, Pasquale Strazzullo, Vincenzo Nunziata.   

Abstract

OBJECTIVES: To investigate the association between fasting idiopathic hypercalciuria (IHc), defined as IHc in the fasting state associated with normal parathyroid function, and ApaI, BsmI, and FokI polymorphisms of the vitamin D receptor (VDR) gene in 159 hypercalciuric recurrent stone formers. IHc contributes to the formation of calcium kidney stones in more than one half of reported cases.
METHODS: We examined 62 patients with fasting IHc (24 women, mean age 42.8 +/- 11.1 years, body mass index 25.7 +/- 4.8 kg/m2), 97 patients with absorptive IHc (41 women, mean age 43.5 +/- 10.8 years, body mass index 26.1 +/- 4.4 kg/m2), and 124 healthy control subjects (52 women, mean age 41.9 +/- 10.4 years, body mass index 25.4 +/- 5.1 kg/m2) without a history of nephrolithiasis and without IHc. The bone mass density and VDR genotype and haplotype frequencies were determined in the studied populations.
RESULTS: A reduced bone mass density was observed in fasting IHc patients compared with absorptive IHc patients (P = 0.009) and control subjects (P = 0.006). The prevalence of ApaI and BsmI VDR genotypes and alleles in patients with fasting IHc was significantly different statistically (P <0.05) from that observed in patients with absorptive IHc and control subjects, and the ba haplotype was overrepresented in these patients. No statistically significant difference in the distribution of FokI VDR genotypes and alleles was found between the studied groups.
CONCLUSIONS: Our results suggest a genetic association between 3' VDR alleles, fasting IHc, and reduced bone mass density in patients with recurrent stone formation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15491743     DOI: 10.1016/j.urology.2004.05.013

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  17 in total

1.  Update on the genetics of nephrolithiasis.

Authors:  Giuseppe Vezzoli; Teresa Arcidiacono; Vera Paloschi; Annalisa Terranegra; Rita Biasion; Laura Soldati
Journal:  Clin Cases Miner Bone Metab       Date:  2008-05

2.  ApaL1 urokinase and Taq1 vitamin D receptor gene polymorphisms in first-stone formers, recurrent stone formers, and controls in a Caucasian population.

Authors:  Serdar Aykan; Murat Tuken; Sezgin Gunes; Yigit Akin; Murat Ozturk; Serkan Seyhan; Emrah Yuruk; Mustafa Zafer Temiz; Ali Faik Yılmaz; Daniel P Nguyen
Journal:  Urolithiasis       Date:  2015-08-15       Impact factor: 3.436

3.  Coding region analysis of vitamin D receptor gene and its association with active calcium stone disease.

Authors:  Abbas Basiri; Nasser Shakhssalim; Massoud Houshmand; Amir H Kashi; Mohaddeseh Azadvari; Banafsheh Golestan; Esmaeel Mohammadi Pargoo; Hamid Pakmanesh
Journal:  Urol Res       Date:  2011-08-04

4.  Metabolic syndrome and nephrolithiasis: can we hypotize a common background?

Authors:  Giuseppe Mossetti; Domenico Rendina; Gianpaolo De Filippo; Domenico Benvenuto; Carmen Liliana Vivona; Giorgia Zampa; Pasquale Ferraro; Pasquale Strazzullo
Journal:  Clin Cases Miner Bone Metab       Date:  2008-05

Review 5.  Genetic basis of renal cellular dysfunction and the formation of kidney stones.

Authors:  Saeed R Khan; Benjamin K Canales
Journal:  Urol Res       Date:  2009-06-11

6.  The relation between bone and stone formation.

Authors:  Nancy S Krieger; David A Bushinsky
Journal:  Calcif Tissue Int       Date:  2012-12-18       Impact factor: 4.333

Review 7.  New insights into the pathogenesis of idiopathic hypercalciuria.

Authors:  Elaine M Worcester; Fredric L Coe
Journal:  Semin Nephrol       Date:  2008-03       Impact factor: 5.299

8.  Vitamin D receptor gene (VDR) polymorphisms and the urolithiasis risk: an updated meta-analysis based on 20 case-control studies.

Authors:  Wentao Liu; Minfeng Chen; Mengjun Li; Hong Ma; Shiyu Tong; Ye Lei; Lin Qi
Journal:  Urolithiasis       Date:  2013-11-05       Impact factor: 3.436

9.  Polymorphisms in the vitamin D receptor and the androgen receptor gene associated with the risk of urolithiasis.

Authors:  Rama Devi Mittal; D K Mishra; P Srivastava; P Manchanda; H K Bid; R Kapoor
Journal:  Indian J Clin Biochem       Date:  2010-05-27

10.  Predisposition of genetic polymorphism with the risk of urolithiasis.

Authors:  Rama D Mittal; Hemant K Bid; Parmeet K Manchanda; Rakesh Kapoor
Journal:  Indian J Clin Biochem       Date:  2008-06-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.